authors have reported higher rates of painful crises, 13 osteone crosis 14 and retinopathy 14 in SCA patients with α thal. Although several studies have described the possible effects of α thal among patients with SCA in the developed world, 57, 914 there is paucity of information about the influence of this genetic factor in African patients with SCA. Although the few available stud ies from Africa have established that the 3.7 κb α globin gene deletion is the common α thal allele among the African popula tion, 1520 nonetheless, there is lack of consensus on its impacts on the laboratory and clinical manifestations of patients with SCA.
1520
Because of genetic variability in different populations, it is perti nent that more studies are carried out among cohorts from different ethnic backgrounds to fully understand the impact of genetic mod ifiers on SCA. The aim of this study was to assess the prevalence of α thal trait and its influence on laboratory parameters and clinical events in a group of young Nigerians with SCA.
| PATIENTS AND ME THODS

| Study design and setting
This was a cross sectional retrospective study conducted on 100 hydroxyurea naive SCA children and adolescents who are regular at tendees at the pediatric hematology unit of the Ekiti State University
Teaching Hospital (EKSUTH), Ado Ekiti, Ekiti State, Southwestern Nigeria.
| Participants' selection and SCA diagnosis
To qualify for inclusion, the SCA patient must be a regular attendee at the unit and must have been on regular follow up at the unit for a minimum of 1 year prior to recruitment with up to date hospital records. Participants with confirmed or other suspected chronic dis eases apart from SCA were excluded. Also excluded were the few SCA patients on regular blood transfusion and hydroxyurea therapy.
SCA was initially diagnosed by hemoglobin electrophoresis and later with high performance liquid chromatography (HPLC) when the facility became available. In addition, SCA was confirmed by DNA studies. Sixty three apparently healthy children who accompanied their siblings to or attended the outpatients' well child clinic served as controls.
| Ethical considerations
Written informed consent of parents/caregivers as well as pa tients' assents and consents were obtained as applicable. The diagnoses of clinical events among all the patients were made from independent reviews by at least two physicians one of whom must be a pediatric hematology specialist. These diagnoses were ar rived at using both clinical skills and appropriate investigations. Data documented on the clinical evolution of the patients with respect to the number of bone pain crises requiring hospital visit, admis sion, and administration of analgesics within the preceding 1 year were retrieved. In addition, the presence or absence of chronic SCA complications including leg ulcers, priapism and overt osteonecrosis or overt stroke were retrieved from the records. The definitions of clinical events were as previously described. 
| Genetic studies
| Alpha thalassemia determination
Alpha thalassemia (α3.7Kb deletion) was investigated by GAP PCR according to Dode et al 23 Other details are provided in the supplemental materials. All DNA studies were carried out blinded regarding the clinical and laboratory parameters of the participants.
| Data analysis
Statistical analysis was performed with the GraphPad Prism Program, Level of significance was set at P < 0.05.
| RE SULTS
The patients consisted of 66 males and 34 females with a median age of 8.5, range 2 21 years. The controls were made up of 22 individuals with HbAS and 41 with HbAA, median age of 8.5, range 2 18 years.
They consisted of 36 males and 27 females. The patients had been on follow up for a median of 4 years, range 1.5 14 years. There were no differences in the socio biographic data of patients and controls (Table 1) .
| Allele frequency of alpha thalassemia among patients and controls
None of the participants had the alpha thal trait due to 4.2Kb 
| Comparison of laboratory parameters between patients and controls
There were significant differences between the patients and con trols in all laboratory parameters P < 0.05 except mean corpuscular hemoglobin (MCH). (Table S1) 
| Effects of alpha thalassemia on hematological indices and other laboratory parameters among patients
Co inheritance of α thal was significantly associated with higher hemoglobin concentration (Hb), red blood cell count (RBC), and HbA 2 level. On the contrary, it was associated with lower mean cor puscular volume (MCV) and mean corpuscular hemoglobin (MCH).
Also, the white blood cell count (WBC) was significantly lower in patients with homozygous 3.7 kb α globin gene deletion com pared to the two other groups. No significant differences were ob served across α thal genotypes in the other laboratory parameters (Table 2 ).
| Effects of alpha thalassemia on clinical events among patients
Sixty one (61.0%) patients were admitted for bone pain episodes in the preceding 1 year. Five (5.0%) had overt stroke, 5 (5.0%) had overt osteonecrosis while 5 (7.5%) males had priapism as chronic compli cations of their SCA.
The rate of painful crisis was higher in patients with α thal com pared to those without it (P < 0.0001). However, the presence of α thal seems to protect against leg ulcer as none of the six patients with leg ulcer had α thal 0 (0.0%) vs 6 (10.3%), P = 0.04. No signif icant association was found in relation to other clinical events with respect to the presence or absence of α thal (Table 3 ).
| D ISCUSS I ON
The two α globin genes on chromosome 16 are located within a 4 kb duplicated region leading to the possibility of rearrangements in cluding deletions and triplications with many attendant downstream consequences. 24 The present study confirmed earlier reports that the 3.7 κb α globin gene deletion is the common α thal allele among Africans 1520 as none of the participants had the 4.2Kb α globin gene deletion.
The prevalence of alpha thalassemia among patients in this study (41%) is comparable to between 37% and 46% earlier described among mixed populations of SCA patients from France 13 and West Africa. 15, 19, 20 This is however higher than the 13% 28% described among patients in the Americas. 2528 These observations may be due to regional differences.
The observed hematological profile of patients with α thal in this study has been previously described. 10, 13, 1820, 25, 26, 28 The increased
Hb and red blood cell count are due to the decrease in the intracel lular concentration of HbS, and number of dense red blood cells. 7 These, in turn, lead to increased red blood cell deformability and decreased rates of both HbS induced RBC polymerization and he molysis. 3, 7, 14 However, the observed pattern of HbA2 and HbF in the patients could be due to the young age of the patients and the effects of β globin genes cluster that appear to modulate both HbF and HbA2 in SCA which were not examined in this study. 29 Beyond these, the hematologic profile of patients with alpha thal assemia also mimics that of iron deficiency anemia. Hence, the sim ilarities between these two conditions further highlight how alpha thalassemia status of children with SCA could impact their care as it may confuse the clinician and, possibly leads to misdiagnosis and or mismanagement for iron deficiency. 3032 This is more important for patients in the developing countries given the high prevalence of both conditions among children in these parts of the world. 30, 32 Contrary to some earlier reports that alpha thalassemia did not influence the clinical events in SCA, 26, 28 in this study, and in agree ment with most published data on this subject, 4,7,13,14 the presence of α thal was associated with higher rates of bone pain crisis com pared to those without α thal. This finding is in keeping with that of Renoux et al, 13 among children with SCA in France and other pre vious reports. 7, 14 Vaso occlusive crisis (VOC) manifesting as bone pain crisis is a common complication of SCA that is thought to be associated with increased blood viscosity. 7, 13 Studies have demon strated that SCA patients with α thal have increased blood viscosity because of relatively higher levels of Hb and/or hematocrit, among other mechanisms. 3, 7, 8, 13, 14, 33 In this study, the SCA patients with α thal had higher Hb that could lead to increased blood viscosity.
Furthermore, as found in this study, authors from different parts of the world have reported that α thal protects against leg ulcer in SCA patients. 10, 11, 17 However, some have reported that no such as sociation exists. 15, 16 These observations reflect lack of consensus on the roles of α thal in some phenotypes of SCA. Leg ulcer is a chronic and debilitating complication that is thought to be associated with very severe phenotype of SCA. 3, 12, 3436 Given the high burden of SCA in Africa, there is need for more studies from this part of the world to explain the relationship between α thal and leg ulcer, and other SCA phenotypes.
The observations that α thal is associated with lower frequency of stroke in children with SCA 37, 38 was not sustained in this study.
On the contrary, one previous study 20 found that, in combination with BCL11A variants, α thal was associated with increased risk for stroke in older SCA patients. The lack of association between α thal and stroke in this study is also in keeping with report by Filho et al 39 Nevertheless, these findings need to be interpreted with caution because of differences in the age of study cohorts and possibility of survival bias. In addition, stroke was determined in this study by overt clinical history and was, in most cases, not confirmed by magnetic resonance imaging or angiography and this could lead to detection bias and exclusion of cases of silent in farcts from our analysis.
The lack of association between α thal and osteonecrosis in this study contrasts with the report by Milner et al 40 on some older children enrolled in the cooperative study of sickle cell dis ease in the USA where they found that, both α thal and increasing age were significantly associated with osteonecrosis. Possible ex planations for our findings included the fact that our study par ticipants were younger compared to that by Milner et al. 40 The youngest patient in this study was 2 years old, while theirs was 5 years old.
This study was limited by the small sample size and young age of the patients. It is also likely that the apparent higher occurrence of the homozygous alpha thalassemia in the patients relative to the control is not real and may be due to the smaller number of the con trols and the small size of this study. Despite these limitations, the study was able to demonstrate that some important SCA pheno types were influenced by the presence of alpha thalassemia among the patients. Hence, this study represents an important contribu tion to the scanty literature on the roles of genetic modifiers in the expression of SCA among patients in the developing countries.
In conclusion, this study shows that coexistence of α thal influ ences the hematologic parameters of Nigerian children with SCA. It also showed that α thal was associated with increased rates of bone pain crisis and protects against the occurrence of leg ulcer among the patients.
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